multistem (Athersys Inc)
86
Structured Review
Athersys Inc
multistem
Multistem, supplied by Athersys Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multistem/pmc13176351-37-5-6
Average 86 stars, based on 1 article reviews
Multistem, supplied by Athersys Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multistem/pmc13176351-37-5-6
Average 86 stars, based on 1 article reviews
multistem - by Bioz Stars,
2026-10
86/100 stars
Images
Related Articles
Derivative Assay:Article Title: The Inflammatory Lung Microenvironment; a Key Mediator in MSC Licensing Article Snippet: .. Positive findings from the completed Athersys MUST-ARDS phase 1/2 randomised, double blind, placebo-controlled exploratory clinical study of other:Article Title: Mesenchymal stem/stromal cell therapy for COVID-19 pneumonia: potential mechanisms, current clinical evidence, and future perspectives Article Snippet: 3 , Article Title: Industry updates from the field of stem cell research and regenerative medicine in October 2023. Article Snippet: Kite (CA, USA; www.kitepharma.com), a Gilead Company (CA, USA; www.gilead.com) and Epicrispr Biotechnologies (CA, USA; https://epic-bio.com) have entered into a research collaboration and license agreement using Epic Bio’s proprietary gene regulation platform to develop next-generation cancer cell therapies [1].. The agreement will allow Kite to leverage the licensed technology to modulate certain genes to potentially enhance chimeric antigen receptor (CAR) T cell functionality. |